Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
about
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
description
clinical trial
@en
klinisch onderzoek
@nl
name
Effect of Adding Vildagliptin ...... l During Metformin Monotherapy
@en
type
label
Effect of Adding Vildagliptin ...... l During Metformin Monotherapy
@en
prefLabel
Effect of Adding Vildagliptin ...... l During Metformin Monotherapy
@en
P4844
P1050
P1476
Effect of Adding Vildagliptin ...... l During Metformin Monotherapy
@en
P3098
NCT01565096
P580
2011-11-01T00:00:00Z
P582
2012-11-01T00:00:00Z